Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
J Cardiothorac Vasc Anesth. 2012 Oct;26(5):857-62. doi: 10.1053/j.jvca.2012.01.015. Epub 2012 Mar 3.
An inhalation anesthetic-induced attenuation effect on the inflammatory reaction during one-lung ventilation (OLV) has been reported. Pulmonary inflammation is a substantive prognostic factor for Ivor Lewis operations. Blood inflammatory parameters and postoperative pulmonary complications between sevoflurane and propofol-remifentanil anesthesia in patients undergoing Ivor Lewis operations were compared.
A prospective, randomized study.
A medical university.
Forty-eight patients undergoing Ivor Lewis operation allocated randomly into 2 groups.
Patients received sevoflurane or total intravenous anesthesia using propofol and remifentanil (n = 24 per group).
Blood interleukin-6 (IL-6), malondialdehyde (MDA), oxygenation, abnormalities on a chest radiograph (CXR), extubation, intensive care unit (ICU) stay, length of hospitalization, and postoperative complications were compared between the 2 anesthetic techniques. The level of IL-6 at the end of surgery was lower for sevoflurane (69.5 [35.9-121.0] pg/mL) than propofol-remifentanil (128.2 [92.8-163.8] pg/mL, p = 0.03), but this difference was not maintained 24 hours after surgery. Frequencies of abnormalities measured by a CXR, PaO(2)/F(I)O(2)<300, and PaCO(2) <50 mmHg until discharge, the postoperative highest C-reactive protein level, white blood cells, and MDA did not differ between the 2 anesthetics. No differences in the extubation time, ICU stay, discharge day, or the incidence of hospital complications between sevoflurane and propofol-remifentanil anesthesia techniques were observed.
Sevoflurane anesthesia attenuated an increase in blood IL-6 at the end of surgery but did not provide any advantages over propofol remifentanil in terms of postoperative pulmonary complications in Ivor Lewis operations.
有报道称,吸入麻醉剂可减轻单肺通气(OLV)期间的炎症反应。肺炎症是 Ivor Lewis 手术的重要预后因素。比较了 Ivor Lewis 手术患者中七氟醚和丙泊酚-瑞芬太尼麻醉下的血液炎症参数和术后肺部并发症。
前瞻性、随机研究。
一所医科大学。
48 名接受 Ivor Lewis 手术的患者,随机分为 2 组。
患者接受七氟醚或使用丙泊酚和瑞芬太尼的全静脉麻醉(每组 24 名患者)。
比较了两种麻醉技术之间的血液白细胞介素 6(IL-6)、丙二醛(MDA)、氧合、胸片(CXR)异常、拔管、重症监护病房(ICU)停留时间、住院时间和术后并发症。手术结束时,七氟醚组的 IL-6 水平(69.5 [35.9-121.0] pg/mL)低于丙泊酚-瑞芬太尼组(128.2 [92.8-163.8] pg/mL,p = 0.03),但这种差异在手术后 24 小时内并未维持。CXR 测量的异常频率、PaO2/FIO2<300 和 PaCO2<50 mmHg 直到出院,术后最高 C 反应蛋白水平、白细胞和 MDA 两组麻醉之间没有差异。七氟醚和丙泊酚-瑞芬太尼麻醉技术之间的拔管时间、ICU 停留时间、出院日或住院并发症发生率没有差异。
七氟醚麻醉可减轻手术结束时血液 IL-6 的增加,但在 Ivor Lewis 手术中的术后肺部并发症方面,与丙泊酚-瑞芬太尼相比,并没有任何优势。